{"id":327657,"date":"2026-08-05T21:22:22","date_gmt":"2026-08-05T21:22:22","guid":{"rendered":"https:\/\/www.europesays.com\/se\/327657\/"},"modified":"2026-08-05T21:22:22","modified_gmt":"2026-08-05T21:22:22","slug":"delar-sankte-novo-nordisk-tyngde-kopenhamnsborsen","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/327657\/","title":{"rendered":"Del\u00e5r s\u00e4nkte Novo Nordisk \u2013 tyngde K\u00f6penhamnsb\u00f6rsen"},"content":{"rendered":"<p>Novo Nordisks aktie tappade 5 procent och drog med sig hela K\u00f6penhamnsb\u00f6rsen i fallet. Nedg\u00e5ngen kommer trots att l\u00e4kemedelsj\u00e4tten redovisat h\u00f6gre f\u00f6rs\u00e4ljning och r\u00f6relseresultat \u00e4n v\u00e4ntat samt h\u00f6jt hel\u00e5rsprognosen.<\/p>\n<p>Marknaden tycks fokusera p\u00e5 att f\u00f6rs\u00e4ljningen av Wegovy i tablettform inte \u00f6vertr\u00e4ffade f\u00f6rv\u00e4ntningarna, n\u00e5got som f\u00f6rv\u00e5nar SB1:s l\u00e4kemedelsanalytiker Johan Unnerus.<\/p>\n<p>\u2013 De levererar tydligt \u00f6ver f\u00f6rv\u00e4ntan vad g\u00e4ller l\u00f6nsamhet och inom diabetes, s\u00e4ger han till TT.<\/p>\n<p>Enligt Unnerus pressas Novo Nordisk fortsatt av Eli Lilly inom injicerbara viktminskningsl\u00e4kemedel, men har ett f\u00f6rspr\u00e5ng p\u00e5 marknaden f\u00f6r viktminskningspiller.<\/p>\n<p>Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? <a href=\"https:\/\/omni.se\/delar-sanker-novo-nordisk-tynger-kopenhamnsborsen\/a\/mailto:redaktion@omni.se\" class=\"ArticleActions-module-scss-module__w9u9BG__contactLink\" rel=\"nofollow noopener\" target=\"_blank\">Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisks aktie tappade 5 procent och drog med sig hela K\u00f6penhamnsb\u00f6rsen i fallet. Nedg\u00e5ngen kommer trots att&hellip;\n","protected":false},"author":2,"featured_media":327658,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,70,71,6631,15365,2741,1206,34,31,33,32,30],"class_list":["post-327657","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-economy","tag-ekonomi","tag-eli-lilly","tag-kopenhamnsborsen","tag-lakemedel","tag-novo-nordisk","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117045005285849631","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/327657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=327657"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/327657\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/327658"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=327657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=327657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=327657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}